A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone.

Authors

Alison M. Boyce, George Washington University
Marilyn H. Kelly
Beth A. Brillante
Harvey Kushner
Shlomo Wientroub
Mara Riminucci
Paolo Bianco
Pamela G. Robey
Michael T. Collins

Document Type

Journal Article

Publication Date

11-2014

Journal

Journal of Clinical Oncology and Metabolism

Volume

Volume 99, Issue 11

Issue

11

Inclusive Pages

4133-4140

Keywords

Alendronate--therapeutic use; Bone Density--drug effects; Bone Density Conservation Agents--therapeutic use; Bone Remodeling--drug effects; Fibrous Dysplasia of Bone--drug therapy

Comments

PMCID: PMC4223439 [Available on 2015/11/1]

APA Citation

Boyce, A.M., Kelly, M.H., Brillante, B.A., Kushner, H., Wientroub, S. et al. (2014). A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. Journal of Clinical Endocrinology and Metabolism, 99(11), 4133-4140.

Peer Reviewed

1